<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02198027</url>
  </required_header>
  <id_info>
    <org_study_id>TIH-Urology-001</org_study_id>
    <secondary_id>IRD_IRB_2014_01_002</secondary_id>
    <nct_id>NCT02198027</nct_id>
  </id_info>
  <brief_title>Peritubal Infiltration of Bupivacaine in PCNL</brief_title>
  <official_title>Role of Peritubal Infiltration of 0.25% Bupivacaine in Percutaneous Nephrolithotomy (PCNL) in Postoperative Pain Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indus Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indus Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients may feel significant pain at the surgery site after they wake up from the surgery.
      Usually pain is managed in the ward by giving strong pain medication that may slow down your
      mobilization and recovery process. Some recent work in other countries has shown that if
      investigator give patients an injection at the end of the operation, patients have less need
      for pain medication when they wake up. If investigator find that is also true in our
      population, then we can use this method as routine step after this operation to improve pain
      management and early mobilization of our patients
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean time for first demand of rescue analgesic</measure>
    <time_frame>Release of the patient from the hospital or 24 hours (whichever comes first)</time_frame>
    <description>Mean time for first demand defined as the difference in time between the first time rescue medications is given to patient in post-operatively and the time the infiltration took place intra-operatively</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Bupivacaine infiltration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 ml of 0.25 % Bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline infiltration</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10 ml of normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>23 G spinal needle will be introduced along the nephrostomy tube for peri-tubal infiltration of 10 ml of 0.25 % Bupivacaine into renal capsule to skin.</description>
    <arm_group_label>Bupivacaine infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal saline infiltration</intervention_name>
    <description>23 G spinal needle will be introduced along the nephrostomy tube for peri-tubal infiltration of 10 ml of normal saline into renal capsule to skin</description>
    <arm_group_label>Normal saline infiltration</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-60 years of age

          -  Single PCNL track

        Exclusion Criteria:

          -  Spinal Disc Prolapse

          -  Any previous renal surgery

          -  Complication secondary to PCNL

               -  Hydrothorax that requires intervention

               -  Pneumothorax

               -  Massive hemorrhage that requires more than 1 U transfusion

               -  Conversion to open procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zeeshan Arshad, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Indus Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zafar Zaidi, MBBS</last_name>
    <role>Study Director</role>
    <affiliation>The Indus Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zeeshan Arshad, MBBS</last_name>
    <email>zeeshandaa@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Naila Baig-Ansari, PhD</last_name>
    <email>naila.baig.ansari@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Indus Hospital</name>
      <address>
        <city>Karachi</city>
        <state>Sind</state>
        <country>Pakistan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naila Baig-Ansari, PhD</last_name>
      <email>naila.baig.ansari@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Zeeshan Arshad, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zafar Zaidi, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2014</study_first_submitted>
  <study_first_submitted_qc>July 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2014</study_first_posted>
  <last_update_submitted>September 20, 2014</last_update_submitted>
  <last_update_submitted_qc>September 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indus Hospital</investigator_affiliation>
    <investigator_full_name>Zeeshan Arshad</investigator_full_name>
    <investigator_title>Resident, Urology</investigator_title>
  </responsible_party>
  <keyword>Percutaneous nephrolithotomy</keyword>
  <keyword>postoperative analgesia</keyword>
  <keyword>peritubal block</keyword>
  <keyword>pain</keyword>
  <keyword>Visual Analog Pain Scale</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

